Established in 1987 as the Aids Clinical Trials Unit (ACTU), the Washington University ACTU has been a highly productive participant in the AIDS Clinical Trials Group and is funded by the National Institute of Allergy and Infectious Diseases. Centrally located in the Midwest, it draws participants from Missouri, Illinois, Arkansas, Kansas, Tennessee, Nebraska and Oklahoma. Within the Division of Infectious Diseases, this ACTU is considered among the finest in the world.
The Washington University Infectious Diseases Clinical Research Unit (ID-CRU), as it is now known, is highly regarded for their expertise and is well established in the community. Led by Rachel Presti, MD, PhD, the ID-CRU provides access to HIV and Infectious Disease research opportunities, community outreach and education.
Team
Andrej Spec, MD, MSCI
Associate Professor of Medicine
- Phone: 314-454-8354
- Fax: 314-454-5392
- Email: aspec@wustl.edu
Dr. Spec‘s research is in fungal infections, particularly in immunocompromised patients, including those with transplants. His research focuses on Cryptococcus, Histoplasma, Candida, Aspergillus and other invasive molds. Dr. Spec also runs the division’s clinic focusing on invasive fungal infections, where he takes care of both immunocompromised and immunocompetent patients with fungal infections, which he considers the best and most rewarding part of his job.
